Literature DB >> 7138618

Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.

T Ishida, K Tanaka.   

Abstract

Fibrin contains a factor which promotes growth of the mesenchymal cells and such may be related tissue repair. Effects of fibrin and fibrinogen degradation products (FDP) on the growth of smooth muscle cells (SMC) of rabbit aortas in culture were investigated, in relation to atherogenesis. Fibrin, free from plasminogen enhanced the proliferation of SMC during the experimental period of 48 h. Fibrin, rich in plasminogen also stimulated the proliferation of SMC within 24 h, but inhibited it after 48 h. FDP (fragments D and E) inhibited the proliferation of SMC. SMC of rabbit aortas demonstrated plasminogen activator activity. Thrombin and urokinase exhibited no promoting effects on the growth of SMC. These results support the hypothesis that the proliferation of SMC is stimulated by fibrin and later inhibited by FDP, as produced by the fibrinolytic activity of SMC. It is proposed that the metabolism of fibrin in the arterial wall may be of importance in the regulation of SMC proliferation and that the coagulation-fibrinolysis system may play a significant role in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138618     DOI: 10.1016/0021-9150(82)90111-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

1.  Microscopic and immunohistological studies on intimal hyperplasia of the arterially implanted autovein graft and its anastomosis in dogs.

Authors:  D R Shrestha; H Shiroma; Y Kamada; A Kusaba
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  TGFβ2 differentially modulates smooth muscle cell proliferation and migration in electrospun gelatin-fibrinogen constructs.

Authors:  Diana C Ardila; Ehab Tamimi; Forest L Danford; Darren G Haskett; Robert S Kellar; Tom Doetschman; Jonathan P Vande Geest
Journal:  Biomaterials       Date:  2014-10-22       Impact factor: 12.479

3.  Repair in arterial tissue 2 years after a severe single dilatation injury: the regenerative capacity of the rabbit aortic wall. The importance of endothelium and of the state of subendothelial connective tissue to reconstitution of the intimal barrier.

Authors:  J Chemnitz; B C Christensen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Time course of arterial repair following endothelial denudation in the rat carotid artery. A morphometric study in Wistar and Sprague-Dawley rats.

Authors:  E van Pelt-Verkuil; J Knoester; W van Pelt; M Brink; D Jense; J J Emeis
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

5.  Intimal hyperplasia: the permeation of serum-derived substance into the arterial autovein graft under abnormal blood flow.

Authors:  M Kuroki; K Okadome; K Inokuchi; K Sugimachi
Journal:  Jpn J Surg       Date:  1988-05

6.  Demonstration of fibronectin in normal and injured aorta by an indirect immunoperoxidase technique.

Authors:  B A Jensen; B Hølund; I Clemmensen
Journal:  Histochemistry       Date:  1983

7.  Repair in arterial tissue. Demonstration of fibrinogen/fibrin in the normal and healing rabbit thoracic aorta by the indirect immunoperoxidase technique.

Authors:  J Chemnitz; B C Christensen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  The rate of re-endothelialization correlates inversely with the degree of the following intimal thickening in vein grafts. Electron microscopic and immunohistochemical studies.

Authors:  Y Shiokawa; M F Rahman; Y Ishii; K Sueishi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships.

Authors:  K Ding; D Feng; M de Andrade; T H Mosley; S T Turner; E Boerwinkle; I J Kullo
Journal:  J Hum Hypertens       Date:  2007-10-25       Impact factor: 3.012

10.  Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.

Authors:  J J Zwaginga; H A Koomans; J J Sixma; T J Rabelink
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.